ESC Professional Premium Access

Residual risk in dyslipidaemias: from statins to PCSK9 inhibitors and beyond.

Congress Presentation

About the speaker

Professor Erik Stroes

Academic Medical Centre, Amsterdam (Netherlands (The))
24 presentations
0 follower

4 more presentations in this session

Residual inflammatory risk.

Speaker: Professor W. Koenig (Munich, DE)

Thumbnail

Residual thrombotic risk: from monotherapy to dual pathway inhibition.

Speaker: Associate Professor B. Rocca (Rome, IT)

Thumbnail

Residual diabetic risk: from glucose lowering to cardiovascular protection.

Speaker: Professor N. Marx (Aachen, DE)

Thumbnail

How to deal with residual cardiovascular risk in atherosclerotic disease? New pharmacotherapeutic options – discussion.

Thumbnail

Access the full session

How to deal with residual cardiovascular risk in atherosclerotic disease? New pharmacotherapeutic options

Speakers: Professor E. Stroes, Professor W. Koenig, Associate Professor B. Rocca, Professor N. Marx
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk